SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-008780
Filing Date
2017-05-04
Accepted
2017-05-04 16:15:42
Documents
3
Period of Report
2017-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-8k_20170504.htm 8-K 20809
2 EX-99.1 rare-ex991_6.htm EX-99.1 96359
3 GRAPHIC g201705041921048304508.jpg GRAPHIC 348834
  Complete submission text file 0001564590-17-008780.txt   598615
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 17814124
SIC: 2834 Pharmaceutical Preparations